A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study to find out whether adding trastuzumab and pembrolizumab to standard chemotherapy is an effective treatment for resectable HER2+ esophagogastric cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby w wieku 18 lat lub starsze.
- •Ogólny stan zdrowia pozwalający na normalną aktywność, z niewielkimi ograniczeniami (status ECOG 0-1).
- •Potwierdzony laboratoryjnie nowotwór przełyku, połączenia przełykowo-żołądkowego lub żołądka z obecnością markera HER2 (HER2-pozytywny).
- •Nowotwór, który można całkowicie usunąć za pomocą operacji.
- •Sprawne narządy wewnętrzne (w tym serce, nerki, wątroba i układ krzepnięcia) – szczegółowe wymagania są podane w dokumentacji badania.
✗ Disqualifies
- •Obecność przerzutów nowotworowych lub nawrót choroby.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 7, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (10)
Massachusetts General Hospital (Data Collection Only)
Boston, United States
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Basking Ridge, United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
Middletown, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
Montvale, United States
Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity)
Commack, United States
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
Harrison, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
Uniondale, United States
University of Pennsylvania (Data Collection Only)
Philadelphia, United States
MD Anderson Cancer Center (Data Collection Only)
Houston, United States
Trial contact
Yelena Janjigian, MD
Samuel Cytryn, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/8/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.